Armata Pharmaceuticals Inc.
ARMP | AMEX
$4.41
+$0.15 (+3.52%)
Sep 22, 2026, 10:30 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.51M | 789K | n/a | n/a | 2.17M | 491K | 1.24M | 2.97M | n/a | 966K | 1.53M | 1.23M | 980K | 796K | 1.05M | 1.34M | 1.88M | 1.24M | 989K | 1.25M | 1.17M | 1.07M |
Cost of Revenue | n/a | 457K | n/a | n/a | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 200K | 9.6M | 9.57M | 8.4M | 9.02M | 8.03M | 4.81M | 5.63M | 5.23M | 4.35M |
Gross Profit | 2.51M | 332K | n/a | n/a | 1.8M | 114K | 855K | 2.66M | -315K | 649K | 1.24M | 1M | 780K | -8.81M | -8.52M | -7.06M | -7.14M | -6.79M | -3.83M | -4.38M | -4.06M | -3.28M |
Operating Income | -10.31M | -8.79M | -13.82M | -7.78M | -6.84M | -8.19M | -10.54M | -9.76M | -11.91M | -10.23M | -9.58M | -10.34M | -9.63M | -11.35M | -10.33M | -8.62M | -9.22M | -8.78M | -6.05M | -6.14M | -6.2M | -5.44M |
Interest Income | 69K | 60K | 131K | 90K | 108K | 59K | 130K | 294K | 221K | 52K | 68K | 47K | 46K | 18K | 14K | 9K | 5K | 1K | 1K | n/a | 2K | 2K |
Pretax Income | 74.14M | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.22M | -8.77M | -6.05M | -5.42M | -6.19M | -5.5M |
Net Income | 74.14M | -115.35M | -124.3M | -26.68M | -16.3M | -6.53M | 2.6M | -5.48M | 8.99M | -25.02M | -19.85M | -31.16M | -3.55M | -14.49M | -10.31M | -8.61M | -9.22M | -8.77M | -6.05M | -5.42M | -6.19M | -5.5M |
Selling & General & Admin | 5.24M | 3.46M | 3.43M | 3.11M | 2.62M | 3.25M | 3.32M | 3.24M | 3.44M | 3.18M | 3.18M | 3.36M | 2.15M | 2.54M | 1.81M | 1.56M | 2.08M | 1.98M | 2.22M | 1.77M | 2.14M | 2.15M |
Research & Development | 7.59M | 6.11M | 6.07M | 5.82M | 6.39M | 5.43M | 8.45M | 9.49M | 8.48M | 8.02M | 7.93M | 7.98M | 8.26M | 9.6M | 9.57M | 8.4M | 9.02M | 8.03M | 4.81M | 5.63M | 5.23M | 4.35M |
Other Expenses | n/a | -457K | 4.33M | -1.16M | -366K | -377K | -379K | -323K | -315K | -317K | -293K | n/a | n/a | -9.6M | -9.57M | -8.4M | -9.02M | -8.03M | -4.81M | -5.63M | -5.23M | -4.35M |
Operating Expenses | 12.82M | 9.12M | 13.82M | 7.78M | 8.65M | 8.31M | 11.39M | 12.41M | 11.6M | 10.88M | 10.81M | 11.34M | 10.41M | 2.54M | 1.81M | 1.56M | 2.08M | 1.98M | 2.22M | 1.77M | 2.14M | 2.15M |
Interest Expense | 6.63M | 5.56M | 4.83M | 4.35M | 3.81M | 3.6M | 3.28M | 2.92M | 2.72M | 1.82M | 1.45M | 1.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | 62K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.82M | 9.57M | 13.82M | 7.78M | 9.01M | 8.68M | 11.77M | 12.73M | 11.91M | 11.19M | 11.11M | 11.56M | 10.61M | 12.14M | 11.38M | 9.96M | 11.1M | 10.01M | 7.04M | 7.39M | 7.36M | 6.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 36.75M | 36.53M | 36.34M | 36.23M | 36.19M | 36.18M | 36.18M | 36.18M | 36.15M | 36.12M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 36M | 29M | 26.3M | 24.82M | 24.76M | 20.46M |
Shares Outstanding (Diluted) | 62.04M | 36.53M | 36.34M | 36.23M | 36.19M | 36.18M | 59.08M | 36.18M | 58.25M | 36.12M | 36.1M | 36.09M | 36.07M | 36.05M | 36.05M | 36.04M | 36M | 29M | 26.3M | 24.82M | 24.76M | 20.46M |
EPS (Basic) | 2.02 | -3.16 | -3.42 | -0.74 | -0.45 | -0.18 | 0.07 | -0.15 | -0.40 | -0.69 | -0.55 | -0.86 | -0.10 | -0.40 | -0.29 | -0.24 | -0.26 | -0.30 | -0.25 | -0.22 | -0.25 | -0.27 |
EPS (Diluted) | -0.27 | -3.16 | -3.42 | -0.74 | -0.45 | -0.18 | 0.04 | -0.15 | -0.25 | -0.69 | -0.55 | -0.86 | -0.10 | -0.40 | -0.29 | -0.24 | -0.26 | -0.30 | -0.25 | -0.22 | -0.25 | -0.27 |
EBITDA | 80.78M | -109.33M | -119.05M | -21.96M | -12.12M | -2.55M | 6.26M | -2.25M | 12.02M | -22.88M | -18.1M | -29.76M | -3.35M | -14.26M | -10.07M | -8.39M | -9.02M | -8.55M | -5.77M | -5.1M | -5.9M | -5.15M |
EBIT | 80.78M | -109.79M | -119.46M | -22.33M | -12.49M | -2.93M | 5.88M | -2.56M | 11.7M | -23.2M | -18.4M | -29.99M | -3.55M | -14.49M | -10.31M | -8.61M | -9.22M | -8.77M | -6.05M | -5.42M | -6.19M | -5.43M |
Depreciation & Amortization | n/a | 457K | 418K | 370K | 366K | 377K | 380K | 313K | 315K | 317K | 293K | 221K | 200K | 230K | 245K | 226K | 195K | 226K | 277K | 314K | 297K | 281K |
Add to Watchlist
Select watchlists to add or remove ARMP